Ionis Pharmaceuticals (IONS) executive compensation, 2026 proxy

Brett P. Monia, Chief Executive Officer, was paid $13.4M in 2025, down 13% from $15.4M the year before. The CEO-to-median-employee pay ratio was 44:1, on median employee pay of $304,680.

Filed
April 23, 2026
Annual meeting
June 4, 2026
Pay year
2025
Named executives
6
CEO total pay
$13.4M-13% vs prior year
CEO to median employee
44:1median $304,680
Prior say-on-pay support
96%of votes cast
CEO Total Compensation
$13,350,777Reported for fiscal year 2025
CEO to Median Employee Pay Ratio
44:1Based on median employee pay of $304,680
Say-on-Pay Support
96%From June 2025 advisory vote

How Monia was paid

$13.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Brett P. MoniaChief Executive Officer$13,350,777
Elizabeth L. HougenEVP, Finance and Chief Financial Officer$4,422,302
Richard S. GearyEVP, Chief Development Officer$3,331,400
Brian BirchlerEVP, Corporate and Development Operations$3,245,054
Eric SwayzeEVP, Research$3,233,339
Patrick R. O’NeilEVP, Chief Legal Officer and General Counsel$3,210,608

What changed and why

  • $15.4MCEO total compensation decreased from $15,400,343 in 2024 to $13,350,777 in 2>**2025**.
  • 96%Stockholders strongly approved the 2025 say-on-pay proposal with approximately 96% support.
  • 33%Beginning in 2026, the proportion of PRSUs increases from 33% to 40% for the CEO and from 20% to 40% for other executives.
  • $400KNon-employee director annual equity compensation was capped at $400,000 in 2026.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.